Ignite Creation Date:
2024-05-06 @ 6:53 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05823987
Status:
RECRUITING
Last Update Posted:
2023-06-27
First Post:
2023-04-11
Brief Title:
Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer OPTIONS-05
Sponsor:
Organization:
Fudan University